2017 is Proving a Big Year for Orphan Drug Designation: Here’s Another One!
In recent news in the oncology community, the FDA has approved orphan drug designation to a new drug, SurVaxM, for glioblastoma. Glioblastoma is a rare type of brain cancer that…